
rais po growth continu surpris
mdt share year believ primarili street
conserv revenu growth outlook allow
beat revenu growth expect last three quarter also greatli
improv clariti guidanc deliv margin promis revenu
growth upsid signific driver stock expect growth
slow absolut term go forward think street continu underestim
growth outlook see less upsid begin
estim grow faster expect multipl cy
today continu expand rais po assum
trade cy ep slight discount peer reiter buy
driver upsid past present futur
last three quarter concern competit small visibl
busi icd deep brain stimul etc caus mani investor miss
strong growth materi emerg market diabet spinal cord
stimul stent go forward expect mdt growth slow diabet
stent spinal cord stim area although mani busi
acceler allow exceed expect keep growth rang
wrap-it studi mdt new spine robot mdt pacer franchis mdt new lvad
left ventricular assist devic indic minim invas approach
bottom granular product product analysi mdt market pipelin
continu drive bullish call
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
medic devic compani
oper four busi segment cardiac
diabet group minim invas therapi
buy rate continu believ
cov deal lower risk profil
better posit win new healthcar
environ longer term exposur
major med-tech growth market see
enough pipelin deliv
revenu growth ep growth go
major restructur near term would
increas investor expect leverag
tabl us ou tavr market trend
note revenu growth market share shown
note revenu growth market share shown
note spine growth rate adjust procedur day pro forma
spine growth exclud sale spine robot
note spine growth rate adjust procedur day pro forma
spine growth exclud sale spine robot
price object base trade cy ep
slight discount peer still think small discount group
warrant given recent execut misstep sever revenu headwind
upsid risk price object greater-than-expect revenu growth new
product robot develop market share gain competit product delay
acceler end-market growth downsid risk price object
competit share loss and/or price pressur
bob hopkin herebi certifi view express research report accur
reflect person view subject secur issuer also certifi
part compens directli indirectli relat specif
recommend view express research report
becton dickinson compani
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
